TriplePoint Venture Growth: Likely More Pain Ahead (Rating Downgrade)
1 sources
Seeking Alpha (US)2h ago
Center
TriplePoint Venture Growth: Likely More Pain Ahead (Rating Downgrade)
Avoid TriplePoint Venture (TPVG): persistent underperformance, high non-accruals and weak dividend coverage threaten another cut by 2027. See more details here.